Childhood Cancer Research Unit
1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma
- Hypoxia and hypoxia-inducible factors in neuroblastoma
- Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer
- Refined control of cell stemness allowed animal evolution in the oxic realm
- A Novel Topical PPAR 3 Agonist Induces PPAR 3 Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models
- Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment
- Genomic Profiles of Neuroblastoma Associated With Opsoclonus Myoclonus Syndrome
- 2017
- Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum
- Anti-Müllerian hormone as a marker of ovarian reserve in girls before, during and after treatment for childhood cancer
- No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms